STOCKS TELEGRAPH

Tag: Pre-Market Movers

  • HWH International (HWH) Undergoes Spontaneous Takeoff in Pre-market Trading

    In a surprising turn of events, HWH International Inc. (NASDAQ: HWH) experienced an explosive surge in premarket trading on Monday, leaving investors astonished. After a rather lackluster performance on Wednesday, where it saw a modest 2% climb, HWH shattered expectations by skyrocketing a staggering 147% in the early hours before the market opened on Thursday. This surge propelled the stock from $1.28 to $3.84, marking a significant leap in value.

    Strong Investor Sentiment

    The heightened interest in HWH was palpable, with the stock trading at nearly ten times its average volume, a clear indicator of the frenzy surrounding it. HWH International, Inc. operates within the lifestyle business sector, employing a membership model to empower individuals in the burgeoning gig economy to achieve lasting wealth.

    Its diverse segments include HWH Marketplace, Hapi Cafe, Hapi Travel Destinations, and Hapi Wealth Builder, each catering to different aspects of its members’ lives.

    Despite the remarkable surge in its stock price, the absence of any significant news has left many investors wary of a potential profit-taking dip in the days ahead. However, for now, bullish sentiment prevails as investors ride the wave of optimism surrounding HWH.

    Recent Transformations

    Since the closing on January 9, 2024, HWH International Inc. has undergone significant transformations, particularly through its recent acquisition pursuant to the Merger Agreement. This acquisition has expanded its reach and capabilities, with a renewed focus on enhancing its membership offerings.

    Originally starting in Korea with a single-level membership marketing model, the company has since evolved its business strategy to adapt to changing market dynamics.

    The impact of the COVID-19 pandemic prompted a reorganization of internal operations, leading to the implementation of a multi-level membership tier model in 2022. This strategic shift, coupled with an expanded product and service portfolio, positions HWH International Inc. for sustained growth and resilience in the face of market uncertainties.

    Conclusion

    As investors await further developments, the remarkable surge in premarket trading underscores the potential of HWH International Inc. to capitalize on emerging opportunities within the lifestyle sector. With a diversified business model and a commitment to innovation, HWH remains a compelling prospect for investors seeking exposure to the dynamic gig economy landscape.

  • ZoomInfo Technologies Inc. (ZI) Flying High in the Premarket Session Following Upbeat Earnings

    ZoomInfo Technologies Inc. (ZI) Flying High in the Premarket Session Following Upbeat Earnings

    ZoomInfo Technologies Inc. (ZI) demonstrated a remarkable performance in the premarket trading session, with its stock price appreciating to $17.77. This surge reflects a significant change of $1.75, translating to an impressive 10.92% increase from the previous close.

    The trading volume in the session stood at 757.55K, indicating a robust interest from investors and possibly reacting to recent company news or market conditions favorable to ZoomInfo.

    Such a substantial premarket change often suggests investor optimism and can be a harbinger of heightened activity and attention toward the company during the upcoming trading day.

    Latest News

    In the latest financial discourse, ZoomInfo (NASDAQ: ZI), a leading platform renowned for its efficacy in streamlining the market outreach process, has unveiled its earnings report for both the final quarter of 2023 and the cumulative fiscal year ending on December 31, 2023.

    Delving into the financial specifics for the fourth quarter, ZoomInfo witnessed a revenue tally of $316.4 million, marking a year-over-year augmentation of 5%. The quarter was further highlighted by an operating income reported under GAAP at $70.5 million, with its adjusted counterpart reaching $126.5 million. Profitability metrics painted a positive picture with GAAP operating margins standing at 22% and an elevated adjusted figure of 40%. The cash flow narrative remained strong with operational cash flow under GAAP hitting $128.8 million, accompanied by an unlevered free cash flow of $126.0 million.

    Extending the fiscal telescope to the entire year, ZoomInfo celebrated a robust increase in GAAP revenue, which soared to $1,239.5 million, up by 13% from the previous year. As per GAAP, the operating income for the year settled at $259.5 million with an adjusted operating income nearly doubling to $498.6 million. The operating income margins were reported at a consistent 21% under GAAP, maintaining an adjusted margin stasis at 40%. The company’s operational efficiency translated into a strong cash flow from operations, which stood at $434.9 million, and an unlevered free cash flow impressively concluded at $463.5 million.

  • ZyVersa Therapeutics Inc: A Comprehensive Analysis of Pre-Market Movers

    ZyVersa Therapeutics Inc: A Comprehensive Analysis of Pre-Market Movers

    ZyVersa Therapeutics Inc (ZVSA), a clinical-stage specialty biopharmaceutical company, has recently emerged as one of the pre-market movers in the financial world.

    This article presents a detailed analysis of ZyVersa’s recent highlights and its significance in the current market scenario.

    Pre-Market Performance: An Overview

    ZyVersa Therapeutics Inc. experienced notable activity in the US stocks pre-market session, with a significant increase in volume by +13.278 million shares.

    The fluctuations in the pre-market performance, with a closing price of 0.0935 USD and a change of +0.0272 USD or +41.03%, have caught the attention of investors worldwide.

    The Rise and Fall: A Snapshot

    The pre-market gap % for ZyVersa stood at +2.71%. However, the current price is at 0.0663 USD, reflecting a change of -10.89%.

    The overall volume during this period was 3.5 million shares, indicating the volatility of ZyVersa’s position in the market.

    Market Cap Analysis

    Despite the fluctuating pre-market performance, the market cap for ZyVersa Therapeutics Inc. stands at 2.885 million USD.

    However, the company has faced a 1-year market cap performance decline of -97.14%. These figures showcase the challenges faced by the company in maintaining a stable position in the market.

    ZyVersa’s Innovative Approach: Inhibiting NLRP3 Inflammasomes

    ZyVersa is currently developing Inflammasome ASC Inhibitor IC 100, a novel approach to treat inflammatory diseases.

    IC 100 can inhibit up to 12 different inflammasomes, including NLRP3 inflammasomes, and their associated ASC specks, which perpetuate damaging inflammation.

    IC 100: A Promising Treatment for Inflammatory Bowel Disease (IBD)

    ZyVersa recently shared findings in an article revealing that restraining NLRP3 inflammasomes can mitigate intestinal inflammation and tissue damage in an animal model of IBD.

    This study adds weight to the potential of inflammasome inhibition as a viable treatment for IBD.

    The Role of IC 100 in Combating Air Pollution-Related Kidney Damage

    ZyVersa has released information on a study showcasing that suppressing NLRP3 inflammasomes can alleviate kidney damage and dysfunction linked to the environmental pollutant PM2.5.

    This research underscores the potential of inflammasome inhibition as a promising treatment avenue for kidney disease, a prevalent health concern impacting over 35 million adults in the United States.

    Investor Insights: An Analysis

    Investors are closely monitoring these fluctuations as they consider their positions in ZyVersa Therapeutics Inc. The combination of ZyVersa’s innovative approaches to treating inflammatory diseases and its volatile pre-market performance presents a unique situation for investors to navigate.

    Conclusion

    Despite the challenges, ZyVersa Therapeutics Inc. continues to show promise with its innovative approaches to treating inflammatory and renal diseases. As one of the pre-market movers, ZyVersa’s performance is closely watched by investors, making it a critical player in the financial world.

  • Pre-Market Movers: A Comprehensive Analysis of Intelligent Bio Solutions Inc.’s Recent Stock Activity

    Pre-Market Movers: A Comprehensive Analysis of Intelligent Bio Solutions Inc.’s Recent Stock Activity

    In the recent financial news, Intelligent Bio Solutions Inc. (INBS), a leading medical technology firm, has demonstrated a robust pre-market performance. This article delves into the company’s stock’s recent activity, shedding light on various aspects of its financial standing.

    Intelligent Bio Solutions: An Overview

    Intelligent Bio Solutions Inc. is a trailblazer in the field of medical technology. With its proprietary Intelligent Fingerprinting Drug Screening System, the company has transformed the landscape of non-invasive, rapid testing solutions.

    The system’s versatility has seen it being adopted by a diverse range of industries, contributing to a steady rise in the company’s revenue.

    Recent Financial Performance

    This firm of the US stocks market has recently unveiled its financial outcomes for the initial fiscal quarter concluding on September 30, 2023.

    It disclosed a substantial year-over-year surge in revenue and government support income, underscoring the effective implementation of its expansion strategies and robust organic growth.

    Revenue Growth

    The company’s combined revenue and government support income rose by 191% to $0.91 million for the first fiscal quarter. This spike is attributed to the launch of its Intelligent Fingerprinting Drug Screening System in the Asia-Pacific region and the acquisition of Intelligent Fingerprinting Ltd in October 2022.

    Net Loss

    The net loss attributable to INBS for the first fiscal quarter was $2.4 million. This increase primarily resulted from the combined results of operations after the acquisition of IFP.

    Cash Flow

    The company ended the quarter with cash and cash equivalents of approximately $0.2 million. However, it managed to raise approximately $4.378 million, prior to deducting underwriting discounts and commissions and offering expenses, via a registered underwritten public offering of the Company’s securities.

    Plans and Milestones

    In its strategic pursuit of growth, INBS has made significant strides in expanding its market presence. The company has successfully entered new markets, including South America, and has continued to grow organically in its existing markets.

    Expansion and Growth

    The firm has made significant progress in its initiatives to extend into the U.S. market. Alongside the creation of novel assays for ketamine and tramadol, INBS has acquired eight fresh clients in Australia, spanning diverse sectors such as mining, aviation, construction, manufacturing, and agriculture.

    Pre-Market Performance

    INBS has showcased an impressive pre-market performance recently, indicating heightened early investor interest. The stock price reflected a significant change of +92.51%, accompanied by a substantial pre-market volume of 220.987 million shares.

    The company’s pre-market change stood at +23.57%, closing at 0.5400 USD. This considerable increase amounted to a pre-market change of 0.1030. The pre-market gap percentage stood at +13.89%, suggesting positive momentum.

    Market Capitalization

    Currently, Intelligent Bio Solutions Inc. holds a market capitalization of 3.817 million USD. Despite experiencing an -84.45% decline over the past year, the company’s recent pre-market performance paints a promising picture for the future.

    Conclusion

    With its strong pre-market performance, Intelligent Bio Solutions Inc. (INBS) has emerged as a key player among pre-market movers. The stock’s recent activity is a testament to the company’s growth strategy, innovative solutions, and successful market expansion. As INBS continues to advance in its field, investors are likely to keep a keen eye on its journey.

  • GAN Limited: A Stellar Show Among Premarket Movers

    GAN Limited: A Stellar Show Among Premarket Movers

    GAN Limited (NASDAQ: GAN) is a leading technology provider of real money internet gaming solutions in North America and a prominent international operator of Internet sports betting. It has recently gained the attention of market participants due to its considerable premarket activity.

    The Premarket Phenomenon

    GAN Limited has been one of the key US stock premarket movers, with a significant trading volume of 926.47 million shares. This was complemented by an impressive pre-market change of 0.8682 USD, representing a whopping increase of 97.35%. The stock also exhibited a pre-market gap of 21.10%, signaling heightened market interest.

    Market Participation During Regular Hours

    Despite the initial surge during pre-market hours, GAN experienced a slight dip in the last regular trading session. The price edged down to 0.8918 USD, marking a change of -0.90%. However, the trading volume during regular hours was still notable, reaching 119.705 million shares. This highlights the strong market participation that GAN has been able to attract.

    Market Capitalization Snapshot

    GAN Limited’s current market capitalization stands at 39.848 million USD. However, over the past year, the company’s performance has faced challenges with a -40.27% decline. This underlines the dynamic nature of GAN stock and the stock’s recent activity.

    Merging Prospects: GAN and Sega Sammy Creation Inc.

    GAN has recently finalized a merger deal with Sega Sammy Creation Inc., a wholly-owned subsidiary of Sega Sammy Holdings, Inc.

    Upon the merger’s completion, each of GAN’s issued ordinary shares will be converted into the right to receive $1.97 per share in cash, signifying a noteworthy premium of 121% over the closing price of GAN’s ordinary shares on November 7, 2023.

    The Way Forward

    The potential merger will be contingent upon the endorsement of GAN’s shareholders. The company will seek the approval of its shareholders through a vote on the Merger Agreement during a Special Meeting of Shareholders.

    If approved, all outstanding GAN ordinary shares will be acquired for $1.97 per share in cash. Consequently, GAN will become a wholly-owned subsidiary of SSC.

     

    Concluding Thoughts

    GAN Limited’s substantial pre-market activity and its impending merger with Sega Sammy Creation Inc. make it a stock to watch among the premarket movers.

    Despite some volatility in the stock’s recent activity, the company’s strategic moves and robust market participation signify its potential for future growth.

     

  • Analyzing NKLA’s Recent Market Activity: A Close Look at the Premarket Movers

    Analyzing NKLA’s Recent Market Activity: A Close Look at the Premarket Movers

    As one of the premarket movers, Nikola Corporation (NASDAQ: NKLA) has experienced a trading volume of 310.248 million shares and a closing price of 1.09 USD.

    Although the pre-market change is minimal at -0.01 USD, which translates to a -0.46% decrease, the pre-market gap of 2.28% indicates considerable market interest.

    NKLA’s Stock Recent Activity

    NKLA’s stock recent activity has also been noteworthy, especially as US stocks regular trading commenced.

    The price dropped to 0.10 USD, marking a substantial change of -3.95%, while the trading volume during regular hours reached 39.262 million shares, indicating active market engagement. Currently, NKLA boasts a market capitalization of 1.079 million USD.

    A Year of Challenges for NKLA

    Unfortunately, the past year has not been particularly kind to NKLA, as it has faced a -20.76% decline. This highlights the dynamic nature of NKLA stock and underscores the importance of closely monitoring the stock’s performance.

    Analyzing the Q3 2023 Earnings Call

    The third quarter of 2023 marked a significant period for Nikola Corporation.

    Conference Call Highlights

    November 2, 2023, the conference call began with Dhillon Sandhu from Investor Relations introducing the attendees, including Steve Girsky, CEO; Stasy Pasterick, CFO; and Christian Appel, Head of Vehicle Platform.

    A press release detailing the financial and business results was distributed earlier, providing interested parties with an overview of the company’s performance.

    CEO’s Remarks

    CEO Steve Girsky provided a clear and concise overview of the company’s current standing and future plans.

    He emphasized Nikola’s focus on developing a network of zero-emission fueling and charging solutions for Class A trucking, with two powertrain options under one truck platform.

    He also outlined the company’s strategic focus on California, given its cutting-edge technology and supportive government regulations for the transition to zero-emission trucking.

    Business Highlights

    Girsky also highlighted the company’s strong sales momentum, despite the voluntary battery recall.

    He mentioned that the company had received wholesale orders for 47 battery-electric trucks from one dealer and had 277 non-binding fuel cell electric truck orders from 35 customers.

    He also announced the hiring of Mary Chan as Chief Operating Officer and Joe Cappello as President of Energy, both of whom bring extensive industry experience to Nikola.

    Closing Remarks

    In his closing remarks, CEO Steve Girsky reiterated his commitment to the company’s mission of decarbonizing heavy-duty commercial transportation.

    He emphasized Nikola’s first-mover advantage with its fuel cell truck and the development of the Hydrogen Highway in California. He also assured investors of the company’s transparency and commitment to keeping its promises.

    In conclusion, NKLA’s recent pre-market activity and stock performance reflect the dynamic nature of the market. Investors should keep a close eye on this premarket mover as it continues to navigate the complex landscape of zero-emission trucking.

  • Pre-Market Analysis: Spotlight on Nxu Inc’s Pre-market Trading Performance

    Pre-Market Analysis: Spotlight on Nxu Inc’s Pre-market Trading Performance

    Nxu Inc (NXU), an innovative domestic technology company garnering attention in the world of electric vehicle (EV) charging and energy storage solutions, has been making waves in the pre-market trading sphere.

    This article provides an in-depth analysis of the recent news surrounding Nxu Inc’s pre-market trading performance and explores the various factors contributing to its notable activity.

    Nxu Inc’s Pre-Market Trading Performance

    Recently, Nxu Inc. experienced a surge in pre-market trading activity. With a trading volume of approximately 6.71 million shares, the company saw its stock price increase modestly by 0.0008 USD, marking a 2.34% rise, closing at 0.0348 USD.

    Regular Trading Session: A Different Picture

    However, as the US stock’s regular trading session commenced, NXU’s performance faced a decline. The stock price fell to 0.0326 USD, marking a change of -4.12%. The trading volume during regular hours was significantly higher, reaching 35.023 million shares, reflecting robust market participation.

    NXU’s Current Market Capitalization

    Nxu Inc. currently holds a market capitalization of 2.273 million USD. The stock’s performance over the past 12 months has seen a -4.12 % change, emphasizing the dynamic nature of the market for NXU.

    Latest activity

    On November 6, 2023, Nxu Inc. (NASDAQ: NXU) made a significant announcement regarding the retirement of the majority of its convertible notes. These notes, totaling $20 million, were initially issued as part of a 2022 private placement involving two investors.

    The private placement included two convertible notes of $10 million each, resulting in two tranches of $9 million each in proceeds for Nxu. The first tranche was disbursed in Q4 2022, followed by the second in Q1 2023.

    Thanks to successful conversions, Nxu has substantially paid off its convertible notes, thereby eliminating the corresponding liabilities from its balance sheet.

    It’s worth noting that the Investors still maintain warrants allowing them to purchase up to 1,711,306 shares of Class A common stock. This strategic move showcases Nxu’s commitment to fortifying its financial position and capitalizing on growth opportunities.

    Nxu One Megawatt+ Charging System: A Game-Changer

    November 7, 2023, NXU has unveiled an exciting new initiative, introducing a subscription service for users of its Nxu One Megawatt+ Charging System.

    For a monthly fee of $69, subscribers gain access to unlimited charging privileges at one of the most formidable public charging stations within the Phoenix metro area.

    This unique charging system offers powerful, standard-agnostic charging, providing EV users with the exact power they need, exactly when they need it. The system is available 24/7, offering convenience and ease to EV users.

    Outlook on Nxu Inc’s Future

    With its innovative charging solutions, Nxu Inc. is positioning itself as an emerging leader in the EV charging industry. The company’s robust intellectual property portfolio and commitment to innovative technology place it at the forefront of e-mobility and energy storage solutions.

    Wrapping Up

    With the company’s ongoing innovation and evolution, it becomes intriguing to observe the trajectory of its stock in upcoming pre-market trading sessions.

    Although recent reports on Nxu Inc’s pre-market performance have presented a mixed picture, the company’s unwavering dedication to innovation and expansion within the EV charging sector positions it as a noteworthy entity to monitor in the years that lie ahead.

  • Top Stocks to Watch Today as Retail Bankruptcies Dampen Outlook

    Top Stocks to Watch Today as Retail Bankruptcies Dampen Outlook

    It’s a mixed day ahead for the U.S equity markets, as the full effects of the coronavirus begin to take effect. The number of permanent job losses in the restaurant market is on the rise, pointing to more pain for the U.S labor market. The number of retail bankruptcies is on the rise too. The Wall Street Journal has reported that the number of bankruptcies is rising faster than many analysts had anticipated. However, even in this environment, there are stocks that are on the rise ahead of markets. The biggest gainers in the current market are mainly in the biotech and energy sectors and are driven by product developments and strong earnings by various industry players. Some of the big players ahead of markets are as below:

    Entera Bio Ltd [NASDAQ:ENTX]

    This is one of the top gainers in pre-market trading and is up by 81% at the time of writing. It’s strong upside momentum after the company announced that it had recorded positive results on its market survey for oral results.  The company has stated that about 85% of clinicians that took part in the survey said they would prescribe PTH in the treatment of moderate and even severe osteoporosis. This is a big deal because PTH can be used to handle the unmet needs that include the improvement of patient comfort. For Entera Bio Ltd, this means that there is a potential to grow in the multibillion-dollar global market focused on the treatment of Osteoporosis. The exposure on market potential by this survey has excited the market and given this stock a renewed optimism.

    Helix Energy Solutions Group Inc [NASDAQ:HLX]

    Helix  Energy Solutions is another top gainer pre-market and is up by 24.51%. The stock’s rally following the release of strong Q2 earnings that beat analysts’ expectations. The company reported an EPS of $0.04 beating analyst expectations of an EPS loss of $0.02.  The company’s revenues also rose to $199.15 million in the quarter, beating analyst expectations by 14.67%. This points to a strengthening of the company’s position in the market.

    Liquid Media Group Ltd [NASDAQ:YVR]

    Liquid Media Group Ltd is another top performer pre-market and is up by 80%. This comes after the company’s announcement that it had partnered with two digital agencies with the goal of transforming its streaming platform. It will be interesting to see how news of the partnership plays out in its price action when markets open.

  • 3 Top Performing Stocks to Watch This Morning: Biotech and Energy Stocks Lead the Way

    3 Top Performing Stocks to Watch This Morning: Biotech and Energy Stocks Lead the Way

    The key stock market indices are down today as the market awaits earnings news and the growing tensions between the U.S and China. Today, China has made a statement against the U.S decision to close the Chinese consulate in Houston, stating that it would take countermeasures against the move by the U.S. The flare-up of tensions between the two countries amidst an ongoing pandemic is reeling the markets. Nonetheless, there are stocks that are gaining strongly ahead of market opening. Most of the big movers pre-market are biotech and energy stocks. Some of the big movers at the moment are as below:

    Bionano Genomics Inc [NASDAQ:BNGO]

    Bionano Genomics Inc [BNGO] is a big mover pre-market and is up by 18% and gaining. BNGO stock has been gaining momentum driven by two recent developments on its biotech projects. Yesterday, Bionano Genomics Inc announced that an international consortium spearheaded by Laila El Khattabi of the Cochin Hospital in France had published a paper touching on the use of Bionano’s Saphyr Genome Imaging instrument. This was with regard to testing the performance of Bionano’s data when compared to the cytogenetic standard of care in the treatment of inherited genetic disorders. The team found that Bionano’s Saphyr was able to detect all; chromosomal aberrations in a total of 85 samples. The positive news came just a few days after BNGO announced that its data is a key part of the first-ever full assembly of a human being’s X-chromosome.  With such positive developments, the momentum around BNGO stock is on the rise even as the rest of the market looks shaky ahead of Mid-week trading.

    Zomedica Pharmaceuticals Corp [NYSE:ZOM]

    Zomedica Pharmaceuticals Corp [ZOM] is another top performer in pre-market trading and is up by 16% at the moment. This follows the ZOM announcement that it had successfully installed TRUFORMA™ remotely. This is a point-of-care diagnostic device that has allowed the company to go ahead with test validation. The  CEO has stated that ZOM is focused on making TRUFORMA™ available in the market soon.

    TransAtlantic Petroleum Ltd [NYSE:TAT]

    This is another top gainer ahead of market opening and is up by 78% pre-market. TransAtlantic Petroleum Ltd [TAT] has been on the rise since it reported financial results for Q1 of 2020. TransAtlantic Petroleum Ltd reported that revenues were down due to the decrease in oil prices. It also added that its hedge at the time was for an oil price of $36 a barrel. Like most energy prices, TAT stock has been buoyed by the increase in oil prices, and its current price action is among the best in the market. Its strong position is also driven by the fact that it was in good cash flow even during the time when oil was at its lowest.

  • 3 Stocks to Watch as Market Sentiment Turns Positive

    3 Stocks to Watch as Market Sentiment Turns Positive

    The markets are in the green pre-market and all the major indices have recorded gains after a mixed performance on Thursday. The increased positive sentiment comes ahead of economic data on housing from the Commerce Department. It is expected that the data will show a recovery in the housing market in spite of the COVID-19 pandemic.  Individual stocks are performing well pre-market too, with some recording exponential gains.  Some of the biggest gainers in pre-market trading are:

    RumbleON Inc [NASDAQ: RMBL]

    This stock has recorded some strong gains pre-market and at one point was up by over 100%. At the moment, its gains are at 97.48%. This stock’s pre-market pump is driven by the company’s announcement that it had started its dealer-centric pilot program with CarGuru. Under the deal, CarGurus will use RumbleON’s technologies for its inventory acquisition product.  Commenting on the deal, RumbleON CEO, Marshall Chesrown stated that the company’s technology continues to serve many dealers. He added that the company’s agnostic approach to business had helped it grow fast and develop relationships in both the automotive and powersport markets. The deal points to a growing market share for RumbleON Inc and is playing into the stock’s price action at the moment.

    Houghton Mifflin Harcourt [NASDAQ: HMHC]

    Houghton Mifflin Harcourt is another top gainer ahead of market opening and is up by 22%. Its strong upside momentum comes hours after the company announced that it had started an online tool for teachers, to facilitate them during this COVID-19 period. Through this tool, the company will help teachers improve their skills, and also connect with other stakeholders in the education sector. The strong positive response that the stock has received in the market point to optimism that the new tool the company has launched has potential in the market. It will be interesting to see how this stock will play out in the day.

    Novavax Inc [NASDAQ: NVAX]

    This is another stock that is showing lots of potential ahead of market opening. The stock is up by 5.89% and gaining. This comes after the company announced that it was joining operation wrap speed. This is a program by the U.S government to help accelerate the development of a COVID-19 vaccine. By joining the program, Novavax will use federal money to complete the development of its COVID-19 vaccine called NVX-CoV2373.  The company will also use the money for its manufacture possibly before the end of 2020.